A movement underfoot in industry is rapidly infiltrating all branches of medicine, and specialties, such as otolaryngology-head and neck surgery, are being encouraged to join the ranks.

Patients who undergo a transnasal esophagoscopy using narrow-band imaging are more likely to have dysplasia diagnosed with a biopsy than those who have the exam using only white light, researchers have reported.
This issue’s Special Report is on quality improvement, an increasingly important health care issue not only in this country, but also in many other countries around the world.
Within the ongoing discussion on the need to reform the delivery of health care in the United States to better balance issues of cost, quality, and accessibility is an underlying issue that, if not sufficiently recognized, will undermine all efforts at reform.
As this article is being written, the presidential campaign is in the final heat, and all eyes are turning toward the finish line.
Cellular therapy refers to the use of live cells to replace or repair a damaged organ system. The first widespread use of this approach occurred more than 50 years ago when hematopoietic stem cells (HSCs) from the bone marrow of a healthy donor (allogeneic) were used to replace the hematopoietic system of a recipient after it was ablated during chemo/radio therapy of leukemia, the recipient’s hematopoietic system being “collateral damage” during the eradication of the unwanted leukemia cells.
Part 1 of a series
In response to many national calls to enhance patient safety, the Accreditation Council for Graduate Medical Education (ACGME) mandated a maximum 80-hour workweek for all residents beginning in 2003.
With the crisis in the financial markets reaching what many call historic proportions, another crisis long brewing is threatening to surface that, if some experts are correct, could have even greater consequences than the financial crisis for the US health care system.